In Our Dog-Eat-Dog Medical Culture, Physicians Lose
For years, physicians have voiced the same frustrations: declining reimbursement, increasing administrative burden, private equity infiltration, insurance company control, expanding ...
FDA’s E-Cigarette Authorization: Fruity Vapes Not Better Than Tobacco Ones
Fruit-flavored e-cigarettes recently authorized by the FDA were not significantly better at helping smokers quit than tobacco-flavored e-cigarettes, according to ...
Endocrine Society Issues First Guideline on Central Precocious Puberty
CHICAGO -- For kids with central precocious puberty (CPP), there shouldn't be a one-size-fits-all approach to testing and treatment, according ...
Talquetamab Regimens Boost Survival in Multiple Myeloma
Talquetamab (Talvey) plus daratumumab (Darzalex) with or without pomalidomide (Pomalyst) significantly improved survival outcomes over an active regimen for relapsed ...
NHS Faces ‘Triple Whammy’ During Resident Doctor Walkout
The NHS faces a ‘triple whammy of pressure’ from striking resident doctors, a predicted heatwave, and England's opening World Cup ...
Over-the-Counter CGM Okayed for Kids
The US FDA extended the age of use for Dexcom’s Stelo down to 2 years. Medscape Medical News Source link ...
Why People Using GLP-1s Are Less Likely to Exercise
Share on PinterestRecent research has found that despite the benefits, people using GLP-1s may be less likely to exercise. Image ...
Study Linking Vaccines to Autism Retracted
A 2010 paper that linked hepatitis B vaccines in infant boys to an increased risk of autism diagnosis was retracted ...
Drinking in Pregnancy on the Rise, CDC Data Show
Alcohol consumption during pregnancy is linked with adverse birth outcomes, like miscarriage and stillbirth, as well as fetal alcohol spectrum ...
FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting
The FDA approved capivasertib (Truqap) in combination with abiraterone (Zytiga) and prednisone for PTEN-deficient prostate cancer, the agency announced on ...
Adjuvant Combination for Kidney Cancer Gets FDA’s Blessing
The FDA on Friday approved belzutifan (Welireg) plus pembrolizumab (Keytruda, Keytruda Qlex) as adjuvant therapy for renal cell carcinoma (RCC) ...
Top Pro Athletes Credit a Tiny New Scope for Their Faster Recoveries
Several top pro athletes and their surgeons say a modern version of an old tool is shaving weeks off the ...
Belzutifan Plus Pembro Approved for Adjuvant RCC
LITESPARK-022 trial reports a 28% decrease in risk for disease recurrence or death. Medscape Medical News Source link : https://www.medscape.com/viewarticle/belzutifan-plus-pembro-approved-adjuvant-rcc-2026a1000jxb?src=rss ...
Massive Medical Equipment Warehouse Burns Down
Firefighters responding to a blaze that destroyed a massive medical equipment warehouse in Northern California and sent embers flying for ...
Renowned Cancer Doc Impersonated in Scam; ‘X-Men’ Actor’s Dx; Lung Screening Woes
Scammers used the identity of Brian Druker, MD, the renowned leukemia researcher known for his work developing imatinib (Gleevec), to ...
Medicare Pays for Programs That May Not Help After Serious Hospitalizations
CMS reimburses for remote patient monitoring, which grew 10-fold from 2019 to 2022, in an effort to cut hospital readmissions.In ...
Novel Oral GLP-1 Shows A1c and Weight-Loss Benefits
The new drug would add another oral GLP-1 with no fasting or fluid intake restrictions to clinicians’ toolboxes, improving options ...
Getting Into a Medical Residency Is Harder Than Ever
Residency spots are more competitive than ever. Here, we look at the good and the bad of the specialties that ...
Psoriasis Workup Expanding Beyond the Skin and Joints
The risk of some psoriasis-associated pathologies, such as cardiovascular disease, are better recognized than others. Medscape Medical News Source link ...
The FDA Issued a Warning on Which Weight-Loss Drug?
The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage ...
